Merdad V. Parsey
2021
In 2021, Merdad V. Parsey earned a total compensation of $6.5M as Chief Medical Officer at Gilead Sciences, a 9% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,640,790 |
|---|---|
| Option Awards | $1,062,502 |
| Salary | $1,024,808 |
| Stock Awards | $2,773,579 |
| Other | $15,000 |
| Total | $6,516,679 |
Parsey received $2.8M in stock awards, accounting for 43% of the total pay in 2021.
Parsey also received $1.6M in non-equity incentive plan, $1.1M in option awards, $1M in salary and $15K in other compensation.
Rankings
In 2021, Merdad V. Parsey's compensation ranked 1,925th out of 12,415 executives tracked by ExecPay. In other words, Parsey earned more than 84.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,925 out of 12,415 | 85th |
Division Manufacturing | 728 out of 5,505 | 87th |
Major group Chemicals And Allied Products | 279 out of 2,375 | 88th |
Industry group Drugs | 238 out of 2,096 | 89th |
Industry Biological Products, Except Diagnostic Substances | 70 out of 449 | 84th |
Pay ratio
| Merdad V. Parsey's Pay | $6,516,679 |
|---|---|
| Median Employee's Pay | $211,687 |
| Pay Ratio | 31to 1 |
In 2021, the annual total compensation of Merdad V. Parsey was $6,516,679.
The annual total compensation of the median employee at Gilead Sciences was $211,687.
The ratio of Merdad V. Parsey's pay to the pay of median employee was therefore 31 to one.
Source: SEC filing on March 24, 2022.
Parsey's colleagues
We found four more compensation records of executives who worked with Merdad V. Parsey at Gilead Sciences in 2021.